Settlement Pressure and Trial Momentum in Social Media Cases

Settlement Pressure and Trial Momentum in Social Media Cases

Marc Rioux and Joe Fantini dive into a busy week in mass torts, covering major developments across Depo-Provera, Social Media Addiction, Roundup, and Uber litigation. Key Takeaways: * Depo-Provera Settlement in Works: Under two years to settlement, potentially 5,000+ cases with hundreds of millions in damages. Judge Rogers vacated trials and Daubert hearings, signaling deal imminent. * Social Media Addiction Going to Trial: Following the $6 million verdict against Meta and a YouTube settlement, the second bellwether trial is expected to settle before jury trial in late July 2026. * Roundup Remand and Supreme Court Ruling Imminent: The case is moving back to Missouri state court with a final approval hearing scheduled for July 2026. A Supreme Court decision on EPA preemption could come by early July, with major ramifications for all pharma MDLs. * Uber's Delay Tactics Rejected by Court: For the third time in the same case, Uber tried to push back trial. The judge denied the request, keeping the September 2026 trial date intact. * Trial Pressure Driving Settlements: Across multiple cases (Depo-Provera, Social Media, Roundup), imminent trials and bellwether pressures are accelerating settlement negotiations.

Why AI Companies Prioritize Growth Over Safety: AI Psychosis, Suicide Cases, and Corporate Negligence

Rachel Lanier and Sarah Lanier, The Lanier Law Firm, join Jon Robinson and Marc Rioux to break down how AI is being weaponized against vulnerable people, and how lawyers are fighting back. Key Takeaways: * ChatGPT and similar AI platforms have provided dangerous advice to vulnerable users, including suicidal youth, prioritizing engagement over safety, a critical issue Rachel and Sarah are litigating. * AI psychosis is an emerging phenomenon where users develop detachment from reality through prolonged AI interactions, creating a new category of mental health cases for trial lawyers. * Only 2% of professionals truly understand how to effectively leverage AI; the remaining 98% use it superficially without understanding its mechanics, creating a significant competitive advantage for those who master it. * The 10-80-10 framework: human oversight on the front end, AI handling 80% of the work, human verification on the back end, is the responsible approach to using AI in litigation. * AI hallucinations are most dangerous in legal research and medical record reading; courts have already rejected multiple cases built on fabricated case law created by AI. * Voice AI agents are becoming indistinguishable from humans, creating ethical nightmares when users believe they're speaking to real people (doctors, lawyers, therapists) receiving critical advice. * Different AI platforms pull from different data sources and training methods; understanding the mechanics of Claude, ChatGPT, Gemini, and Perplexity is essential to choosing the right tool for the right task. * Trial lawyers now face a new defense strategy: blaming AI hallucinations, even when AI systems provided explicit, demonstrable evidence against corporate defendants. * Meta pulled lawsuit advertisements after losing the California social media trial, signaling that tech companies view legal accountability as a threat to be eliminated, not addressed. * The arms race between AI companies (OpenAI, Google, Anthropic) to release new models faster is directly causing safety compromises and unreleased QA testing that endangers users.

The $60M NEC Setback, Talc Dismissal Tactics, and AFFF Docket Cleanup

Key Takeaways * NEC $60M Verdict Overturned: The Illinois appellate court reversed a massive 2024 plaintiffs' verdict due to improper jury instructions regarding failure to warn claims and the improper handling of prejudicial executive compensation evidence, forcing a retrial. * J&J Seeks Total Talc Dismissal: Capitalizing on a recent California defense verdict and the subsequent withdrawal of two key plaintiffs' experts, Johnson & Johnson is aggressively pushing to dismiss the entire MDL with prejudice, a move the plaintiffs' bar plans to fiercely oppose using alternative experts. * AFFF Docket Cleanup Underway: Defendants in the AFFF individual personal injury litigation are moving to dismiss roughly 10,000 cases over missing fact sheets and unverified diagnoses. This mass inventory purging is viewed as a highly positive signal that defendants are calculating viable case counts ahead of potential settlement negotiations. * Lone Pine Constraints: Due to a Lone Pine order currently in place for the AFFF personal injury docket, the litigation is becoming increasingly technical and challenging, meaning explosive new case-filing volume is highly unlikely. * Global Pressures on Social Media Tech: The UK has announced a sweeping ban on social media for children under 16 effective in 2027. Combined with similar bans in Australia and Spain, plus upcoming mainstream whistle-blower media, global regulatory and legal pressures are forcing major tech platforms onto the defensive.

Tax Strategy for Trial Lawyers: Act 60, Penalty Refunds, and Clean Books

Key Takeaways * A Supreme Court ruling has opened up $170 billion in AIPA tariff refunds for importers and downstream businesses, creating a major niche co-counsel opportunity for law firms. * Acting quickly before suppliers receive their tariff refunds makes reimbursement conversations much smoother and less adversarial for downstream businesses. * Moving to Puerto Rico under Act 60 allows attorneys to eliminate short-term and long-term capital gains and lower business tax rates to 4% via export services companies. * Law firms can recover past IRS penalties and interest through the Kwong case FEMA extension, but the deadline closes on July 10, 2026. * The IRS relies on a secretive "DIF score" algorithm to select returns for audits, frequently targeting disproportionate marketing and entertainment expenses. * Less than half of law firms have adequate financial records when entering private equity negotiations, which directly lowers their EBITDA valuation multiples. * Successfully scaling or selling a law firm requires a comprehensive advisory team, including M&A counsel, tax counsel, an ethics specialist, and a highly skilled CPA.

New MDLs Formed, J&J’s Talc Defense Verdict, and Major Paraquat Updates

Key Takeaways * Two New MDLs Established: The JPML has officially formed two new mass tort dockets: the Dupixent litigation in the District of New Jersey and the Spinal Cord Stimulator litigation against Boston Scientific in the Central District of California. * Dupixent Injury Focus: The Dupixent MDL targets a rare T-cell subtype of non-Hodgkin lymphoma , drawing from a massive potential pool of roughly 800,000 users and projected to eventually encompass a few thousand cases. * Spinal Cord Stimulator Scope Limited: Plaintiffs requested an industry-wide spinal cord stimulator MDL, but the JPML limited the initial consolidation to Boston Scientific due to distinct discovery tracks and trade secret concerns. An Abbott Laboratories MDL may follow later this year or early next year. * J&J Clinches Talc Victory: Johnson & Johnson secured a surprising 10-2 defense verdict in the second California state court talc bellwether trial. The outcome came down to a battle of the experts, where jurors expressed skepticism over plaintiff experts who failed to warn their own patients of the risks. * Paraquat Settlement Disruption: In the Paraquat MDL, the judge ordered a mandatory 10% case-specific workup and depositions for three law firms whose clients overwhelmingly opted out of a recent settlement proposal. Concurrently, Philadelphia state court cases are facing renewed jurisdiction challenges ahead of late-summer trials.